Home  >  News
you can get e-magazine links on WhatsApp.Click here
  Adocia’s partner Tonghua Dongbao gets China NMPA nod to begin phase 3 trial of Ultra-Rapid Insulin BioChaperone Lispro to treat type 1 & type 2 diabetes,   October 16, 2021
  UNION therapeutics begins patient enrollment in OSIRIS phase 2a study of oral orismilast to treat mild to severe hidradenitis suppurativa,   October 16, 2021
  New four-year data show Chugai's Enspryng significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder,   October 16, 2021
  Novartis presents positive data from Kesimpta in people living with relapsing multiple sclerosis at ECTRIMS,   October 16, 2021
  InflaRx completes enrollment in phase III part of phase II/III vilobelimab study in severe Covid-19 patients,   October 14, 2021
  Astellas, Seagen complete enrollment in phase 1b/2 EV-103 trial of Padcev in combo with Keytruda to treat advanced urothelial cancer,   October 14, 2021
  Bristol Myers Squibb presents positive results from phase 3 DAYBREAK trial of Zeposia in patients with relapsing forms of multiple sclerosis,   October 14, 2021
  Sanofi presents positive data from phase 2b long-term extension study of tolebrutinib to treat relapsing forms of multiple sclerosis at ECTRIMS 2021,   October 14, 2021
  Ascletis to present results from phase IIa trial of ASC22 in patients with chronic hepatitis B at the Liver Meeting 2021,   October 13, 2021
  Apeiron Biologics begins phase 1 trial to treat Covid-19 with inhaled APN01,   October 13, 2021
  Kintor Pharma gets China NMPA nod to begin clinical trial of ALK-1 and Nivolumab combo therapy to treat advanced hepatocellular carcinoma,   October 12, 2021
  Regenxbio presents positive data from phase II ALTITUDE trial of RGX-314 to treat diabetic retinopathy using suprachoroidal delivery at ASRS meeting,   October 12, 2021
  4D Molecular presents Interim results from 4D-125 phase 1/2 trial in patients with advanced X-linked retinitis pigmentosa at ASRS meeting,   October 12, 2021
  AstraZeneca's TACKLE phase III Covid-19 treatment trial of AZD7442 meets primary endpoint,   October 12, 2021
  Mirati collaborate with Sanofi on phase 1/2 study evaluating combo of adagrasib with SHP2 inhibitor in KRAS G12C-mutated lung cancer,   October 09, 2021
  Amgen to present Lumakras combination data from phase 1b CodeBreaK 101 study in patients with KRAS G12C-mutated cancers at AACR-NCI-EORTC 2021,   October 09, 2021
  Novartis to present range of data from comprehensive MS portfolio at ECTRIMS,   October 08, 2021
  Sanofi announces positive results from first study of Fluzone High-Dose Quadrivalent vaccine with Moderna’s Covid-19 mRNA booster dose,   October 08, 2021
  Bristol Myers’ phase 2 study of deucravacitinib to treat moderate to severe ulcerative colitis fails to meet primary efficacy endpoint,   October 08, 2021
  Baxter presents data from 3 critical care studies at ERSICM LIVES congress,   October 07, 2021

Copyright © 2016 Saffron Media Pvt. Ltd |